Timothy McAlindon to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications Timothy McAlindon has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
0.621
-
Honvo G, Bannuru RR, Bruy?re O, Rannou F, Herrero-Beaumont G, Uebelhart D, Cooper C, Arden N, Conaghan PG, Reginster JY, Thomas T, McAlindon T. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Drugs Aging. 2019 04; 36(Suppl 1):145-159.
Score: 0.621